⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
GOSS 2-WEEK DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS
prnewswire.com
GOSS
Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
GOSS
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
GOSS
Form 8-K
sec.gov
GOSS
Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support
businesswire.com
GOSS
Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support
businesswire.com
GOSS
GOSS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
Class Action Lawsuit Reminder from Pomerantz LLP for Investors of Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
businesswire.com
GOSS
Pomerantz LLP Updates Investors on Legal Action Brought Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS